Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results (vol 28, pg 1017, 2012)

被引：0

|

作者：

Nobels, F.

D'Hooge, D.

Crenier, L.

机构：

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2012年 / 28卷 / 09期

关键词：

D O I：

10.1185/03007995.2012.716999

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

收藏

页码：1546 / 1546

页数：1

相关论文

共 50 条

[1] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results
Nobels, Frank
D'Hooge, Dirk
Crenier, Laurent
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1017 - 1026
[2] Improvement in Metabolic Control in Type 2 Diabetic Patients after Switching from Biphasic Human Insulin to Biphasic Insulin Aspart 30/70: An Observational Study in Hungary
Geroe, Laszlo
Gyimesi, Andras
Hidvegi, Tibor
DIABETES, 2009, 58 : A527 - A527
[3] A comparison of pharmocodynamics and pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 & Pure Insulin Aspart in type 1 diabetes
Thorisdottir, Rannveig L.
Parkner, Tina
Chen, Jian-Wen
Ejskjaer, Niels
Christiansen, Jens S.
DIABETES, 2007, 56 : A555 - A555
[4] Switching from biphasic human insulin to biphasic insulin aspart 30 in type 2 diabetes: Results from the ASEAN subgroup of the A1chieve study
Hussein, Zanariah
Lim-Abrahan, Mary Anne
Jain, Anand B.
Goh, Su Yen
Soewondo, Pradana
DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 : S24 - S29
[5] IMPROVE (TM) observational study of biphasic insulin aspart 30/70 in patients with Type 2 diabetes mellitus
Kawamori, Ryuzo
Valensi, Paul
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 507 - 516
[6] Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: Results from a large, observational study
Jang, Hak Chul
Lee, So Ra
Bech, Ole M.
DIABETES, 2008, 57 : A135 - A135
[7] Clinical Effectiveness of Biphasic Insulin Aspart 30:70 Versus Biphasic Human Insulin 30 in UK General Clinical Practice: A Retrospective Database Study
Morgan, Christopher Li
Evans, Marc
Toft, Anders D.
Jenkins-Jones, Sara
Poole, Chris D.
Currie, Craig J.
CLINICAL THERAPEUTICS, 2011, 33 (01) : 27 - 35
[8] Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: results from a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 in routine clinical practice
Shestakova, M. V.
Akil, Ballan
DIABETES MELLITUS, 2010, 13 (01): : 92 - 100
[9] LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS
Ligthelm, R.
Christensen, T. E.
Thomsen, T. L.
Yang, W.
VALUE IN HEALTH, 2009, 12 (07) : A402 - A402
[10] COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING
Suchankova, E.
Dolezal, T.
Pisarikova, Z.
Rychna, K.
Bartaskova, D.
VALUE IN HEALTH, 2009, 12 (07) : A405 - A406

← 1 2 3 4 5 →